In summary, findings obtained in our study supported the notion that TEV-packaged miR-142-5p could enhance the radiosensitivity of NPC cells by blocking the HGF/c-Met and EGF/EGFR pathways (Fig. 8). The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.